CEGA, a Charles Taylor company, has partnered with Millstream Underwriting to provide its new automated medical screening tool, Antidote, to Millstream’s high-net-worth and other travel insurance customers.
Millstream Underwriting, part of the Nexus Group, specialises in tailoring accident and health insurance solutions for commercial and retail customers in the UK and beyond.
Antidote has been developed by CEGA to further enhance its innovative and end-to-end travel risk management, assistance and claims solutions for global insurers. It provides agile and accurate risk profiling and simplifies travel insurance customers’ medical assessment journeys.
Specifically, the tool allows customers to self-declare pre-existing medical conditions easily via logical question sets and is supported by intuitive technology that recognises a comprehensive range of medical conditions. CEGA is fully involved in its implementation; integrating it seamlessly with Millstream’s existing systems.
CEGA’s head of proposition development, Angela Smith, says, “We’re delighted to be working collaboratively with Millstream to offer this flexible, unique and truly customer-focused service that draws on our 25 years’ experience of medical screening.
“We expect Antidote to pave the way for enhanced policy renewals and sales; providing Millstream with measurable algorithmic outputs and consistency in underwriting outcomes. Crucially, it also offers ownership of customer data.”
Tim Brangwyn, managing director of Millstream Underwriting, comments, “We chose Antidote for its ability to provide a simple, fast and customer-centric medical screening process; enabled by straightforward questions and easy, well-supported technology. Its versatility also allows us to meet the needs of our clients who need a more tailored screening solution.
“CEGA’s professionalism, flexibility and alignment with Millstream’s goals were key factors in establishing this important partnership.”